Literature DB >> 18470650

Liver-directed gene therapy using the sleeping beauty transposon system.

Lalitha R Belur1, R Scott McIvor, Andrew Wilber.   

Abstract

Sleeping Beauty (SB) is a transposon system genetically reconstructed from teleost fish that mediates chromosomal integration of DNA sequences by a cut-and-paste mechanism. SB has been shown to mediate transposition in a variety of cells and tissues, has been used for the generation of transgenic animals and has been tested as a vector for gene therapy in several animal models of human disease. Here, we describe methods that we have developed for testing SB-mediated transposition, first in cultured mammalian cells, and then in vivo using a combination of rapid, high-volume tail vein injection for DNA delivery to the liver along with in vivo bioluminescence imaging to monitor sustained luciferase gene expression in individual animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18470650     DOI: 10.1007/978-1-60327-248-3_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo.

Authors:  Kelly M Podetz-Pedersen; Vaiva Vezys; Nikunj V Somia; Stephen J Russell; R Scott McIvor
Journal:  Hum Gene Ther       Date:  2014-09-22       Impact factor: 5.695

2.  Sleeping beauty system to redirect T-cell specificity for human applications.

Authors:  Sourindra N Maiti; Helen Huls; Harjeet Singh; Margaret Dawson; Matthew Figliola; Simon Olivares; Pullavathi Rao; Yi Jue Zhao; Asha Multani; Ge Yang; Ling Zhang; Denise Crossland; Sonny Ang; Hiroki Torikai; Brian Rabinovich; Dean A Lee; Partow Kebriaei; Perry Hackett; Richard E Champlin; Laurence J N Cooper
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

3.  Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the Sleeping Beauty Transposon System.

Authors:  Lalitha R Belur; Kelly M Podetz-Pedersen; Brent S Sorenson; Alice H Hsu; Josh B Parker; Cathy S Carlson; Daniel A Saltzman; S Ramakrishnan; R Scott McIvor
Journal:  Mol Cancer       Date:  2011-02-10       Impact factor: 27.401

4.  The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions.

Authors:  Svetlana Gershburg; Joshua Geltz; Karin E Peterson; William P Halford; Edward Gershburg
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

5.  Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.

Authors:  Joshua J Geltz; Edward Gershburg; William P Halford
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 6.  A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase.

Authors:  Kelly M Podetz-Pedersen; Erik R Olson; Nikunj V Somia; Stephen J Russell; R Scott McIvor
Journal:  Mol Ther Nucleic Acids       Date:  2016-01-19       Impact factor: 10.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.